Announced Thu, 30 Jul · 16:15 IST
7,53,334 shares allotted on conversion of warrants
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-12.7%1-day move
₹19.46
prior close
₹20.40
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-2.1-0.1-0.1-5.6-12.7-13.5-9.0-12.6-7.6-7.6-15.4-18.6——
Up moveDown movePending
AI summary
Venmax Drugs allotted 7,53,334 equity shares to non-promoter Dinesh Muddu Kotian on conversion of warrants at Rs 20 per share (Rs 10 face value plus Rs 10 premium). The company received the balance 75 percent exercise money of about Rs 1.13 crore. Paid up equity capital rose to Rs 14.48 crore across 1.44 crore shares. Of the original 1 crore warrants issued in March 2025, 7,80,001 remain outstanding for conversion.
Likely market impact
Small dilution as 7.53 lakh new shares are issued; the company raised about Rs 1.13 crore. 7.8 lakh more warrants pending conversion may dilute further.